372 results on '"Hanna, Luke Elizabeth"'
Search Results
2. Antibacterial and Anti-HIV Metabolites from Marine Streptomyces albus MAB56 Isolated from Andaman and Nicobar Islands, India
3. Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS Trial
4. The expression of HIV-1 tat in Lactococcus lactis
5. Host lipidome and tuberculosis treatment failure.
6. Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women
7. Prevalence and factors associated with tuberculosis infection in India
8. T helper cell-mediated epitranscriptomic regulation via m6A RNA methylation bridges link between coronary artery disease and invasive ductal carcinoma
9. Comparison of Real-time RT-PCR cycle threshold (Ct) values with clinical features and severity of COVID-19 disease among hospitalized patients in the first and second waves of COVID-19 pandemic in Chennai, India
10. Trans cohort metabolic reprogramming towards glutaminolysis in long-term successfully treated HIV-infection
11. A facile method of mapping HIV-1 neutralizing epitopes using chemically masked cysteines and deep sequencing
12. Evaluation of platelet indices as markers of tuberculosis among children in India
13. Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review
14. Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children – a cross-sectional observational study from southern India.
15. Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals.
16. Molecular characterization of Enterococcus faecalis isolates from urinary tract infection and interaction between Enterococcus faecalis encountered Dendritic and Natural Killer cells
17. The Expression of HIV-1 Tat inLactococcus lactis
18. Experimental models for HIV latency and molecular tools for reservoir quantification—an update
19. Nanomedicine perspective in HIV therapy: biosynthesized gold nanoparticles exhibiting enhanced anti-HIV property
20. Coinfection with Mycobacterium tuberculosis and HIV
21. HLA based selection of epitopes offers a potential window of opportunity for vaccine design against HIV
22. Molecular mechanisms of action, resistance, detection to the first-line anti tuberculosis drugs: Rifampicin and pyrazinamide in the post whole genome sequencing era
23. In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha
24. Functional and Protective Role of Neutralizing Antibodies (NAbs) Against Viral Infections
25. Contributors
26. Multiplexed next-generation sequencing and de novo assembly to obtain near full-length HIV-1 genome from plasma virus
27. Structural analysis and molecular dynamics simulation studies of HIV-1 antisense protein predict its potential role in HIV replication and pathogenesis
28. Immune cell cross talk in the establishment of HIV-1 latency
29. Insights into RpoB clinical mutants in mediating rifampicin resistance in Mycobacterium tuberculosis
30. Dissection of HIV-1 Protease Subtype B Inhibitors Resistance Through Molecular Modeling Approaches
31. Computational Analysis of Reverse Transcriptase Resistance to Inhibitors in HIV-1
32. Immune Cell Cross Talk in the Establishment of Human Immunodeficiency Virus-1 Latency.
33. QuantiFERON Supernatant-Based Host Biomarkers Predicting Progression to Active Tuberculosis Disease Among Household Contacts of Tuberculosis Patients
34. Comparison of two mycobacterial strains in performance of the whole blood mycobacterial growth inhibition assay in Indian children
35. Design of human immunodeficiency virus-1 neutralizing peptides targeting CD4-binding site: An integrative computational biologics approach
36. MicroRNAs as diagnostic biomarkers for Tuberculosis: A systematic review and meta- analysis
37. Inactivated COVID-19 vaccines: durability of Covaxin/BBV152 induced immunity against variants of concern
38. QuantiFERON Supernatant-Based Host Biomarkers Predicting Progression to Active Tuberculosis Disease Among Household Contacts of Tuberculosis Patients.
39. A user-friendly web portal for analyzing conformational changes in structures of Mycobacterium tuberculosis
40. Transcriptional Profiling and Deriving a Seven-Gene Signature That Discriminates Active and Latent Tuberculosis: An Integrative Bioinformatics Approach
41. Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women
42. Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study
43. R-loop modulated epigenetic regulation in T helper cells mechanistically associates coronary artery disease and non-small cell lung cancer
44. A Note on Derivatives of Isoniazid, Rifampicin, and Pyrazinamide Showing Activity Against Resistant Mycobacterium tuberculosis
45. Challenges in the early diagnosis of HIV infection in infants: Experience from Tamil Nadu, India
46. Toll like receptor (2 and 4) expression and cytokine release by human neutrophils during tuberculosis treatment-A longitudinal study
47. Trans Cohorts Metabolomic Modulation Following Long-Term Successful Therapy in HIV-Infection
48. Systemic Inflammation and Microbial Translocation Are Characteristic Features of SARS-CoV-2-Related Multisystem Inflammatory Syndrome in Children
49. Homology modeling, substrate docking, and molecular simulation studies of mycobacteriophage Che12 lysin A
50. Resistance-associated epitopes of HIV-1C—highly probable candidates for a multi-epitope vaccine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.